DNA Labs UAE is at the forefront of genetic diagnostics, offering a comprehensive array of tests aimed at deciphering the complex code embedded within our DNA. Among these, the SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test stands out for its crucial role in diagnosing a rare but impactful eye disorder. This test, priced at 4400 AED, is designed to detect mutations in the SLC4A11 gene, which have been linked to the development of Corneal Endothelial Dystrophy Type 2, a condition affecting the cornea’s inner layer.
Symptoms of SLC4A11 Gene Corneal Endothelial Dystrophy Type 2
Corneal Endothelial Dystrophy Type 2 is characterized by a range of symptoms that primarily affect the eyes. Understanding these symptoms is key to seeking timely medical intervention and managing the condition effectively. The most common symptoms include:
- Blurred Vision: One of the earliest signs of the condition is a gradual loss of clarity in vision, making it difficult to see fine details.
- Pain and Discomfort: Affected individuals may experience a sense of discomfort or pain in the eyes, which can vary from mild to severe.
- Photophobia: Sensitivity to light, or photophobia, is another symptom that people with this condition often report.
- Corneal Swelling: The cornea may swell due to fluid buildup, leading to further deterioration of vision.
- Visual Halos: Some individuals may see halos around lights, a symptom that can be particularly noticeable at night.
These symptoms are indicative of the progressive nature of Corneal Endothelial Dystrophy Type 2, underscoring the importance of early diagnosis and intervention.
Understanding the SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test
The SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test offered by DNA Labs UAE is a critical tool in the diagnosis and management of this condition. By analyzing the SLC4A11 gene for specific mutations, this test can confirm the presence of Corneal Endothelial Dystrophy Type 2, facilitating early and effective treatment strategies. At a cost of 4400 AED, the test is a valuable investment in one’s ocular health, offering insights that can significantly impact treatment outcomes.
It is important to note that the presence of symptoms alone does not confirm the diagnosis of Corneal Endothelial Dystrophy Type 2. The genetic test serves as a definitive method for diagnosis, providing a clear path for personalized treatment plans.
Why Choose DNA Labs UAE?
DNA Labs UAE stands out for its commitment to providing accurate, reliable, and timely genetic testing services. With state-of-the-art facilities and a team of experienced professionals, the lab ensures that each test, including the SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test, is conducted with the utmost precision and care. For those seeking more information or wishing to schedule a test, please visit https://dnalabsuae.com/tests/slc4a11-gene-corneal-endothelial-dystrophy-type-2-genetic-test/.
In conclusion, the SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test is a vital resource for individuals experiencing symptoms related to this condition. By enabling early diagnosis and personalized treatment, the test represents a significant step forward in the management of Corneal Endothelial Dystrophy Type 2, offering hope and improved quality of life for those affected.
